Mumbai, July 22 (IANS) Dr Reddy’s Laboratories on Wednesday reported a 69 per cent year-on-year (YoY) decline in its consolidated net profit for the first quarter of FY27, with earnings taking a hit from lower revenues in its global generics business, declining North America sales and disruptions in semaglutide supplies.According to the company’s regulatory filing with the National Stock Exchange (NSE), net profit attributable to the owners of the company stood at Rs 4,435 crore during the April…
Latest Wegovy News & Updates
New Delhi, March 27 (IANS) Major drug maker Dr. Reddy’s Laboratories on Friday told the Delhi High Court that it will change the brand name of its semaglutide drug from ‘Olymviq’ to ‘Olymra’, a report said on Friday.The company informed the court that it would propose a new brand name following the judge’s observation that the existing name could lead to confusion in a pharmaceutical setting.The dispute comes as India opens up to generic versions of semaglutide following patent expiry, trigg…